Two Onc Docs

ASCO 2024 Plenary: ADRIATIC Trial in Limited Stage Small Cell Lung Cancer

Jul 8, 2024
Guest
Spigel
Dr. Spigel presents the ADRIATIC trial at ASCO 2024 focusing on Durvalumab in LS-SCLC. Topics include staging imaging, treatment approaches, trial results with improved outcomes, and future trials in small cell lung cancer space.
Ask episode
Chapters
Transcript
Episode notes
1
Intro
00:00 • 3min
2
Importance of Staging Imaging and Treatment Approach for Limited Stage Small Cell Lung Cancer
02:34 • 3min
3
Advancements in Treatment for Limited Stage Small Cell Lung Cancer: The Adriatic Trial
05:20 • 2min
4
Discussion on Study Results in Limited Stage Small Cell Lung Cancer
07:45 • 2min
5
Exploring Findings of the ADRIATIC Trial and Future Trials in Limited Stage Small Cell Lung Cancer
09:23 • 3min